Prostatis Group’s Duke Energy DUK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$392K Buy
2,993
+115
+4% +$14.4K 0.1% 115
2025
Q4
$337K Buy
2,878
+18
+0.6% +$2.2K 0.08% 126
2025
Q3
$354K Sell
2,860
-103
-3% -$12.5K 0.09% 113
2025
Q2
$350K Sell
2,963
-367
-11% -$43.3K 0.1% 110
2025
Q1
$406K Sell
3,330
-300
-8% -$34.2K 0.13% 101
2024
Q4
$391K Buy
3,630
+418
+13% +$47.4K 0.11% 114
2024
Q3
$370K Sell
3,212
-163
-5% -$18.1K 0.12% 104
2024
Q2
$338K Sell
3,375
-689
-17% -$68.9K 0.12% 112
2024
Q1
$393K Buy
4,064
+477
+13% +$45.3K 0.15% 102
2023
Q4
$348K Buy
3,587
+361
+11% +$32.8K 0.15% 99
2023
Q3
$297K Sell
3,226
-88,596
-96% -$8.12M 0.15% 87
2023
Q2
$286K Buy
91,822
+88,863
+3,003% +$8.39M 0.13% 93
2023
Q1
$291K Sell
2,959
-21
-0.7% -$2.08K 0.15% 82
2022
Q4
$307K Buy
2,980
+385
+15% +$37K 0.19% 76
2022
Q3
$241K Buy
2,595
+725
+39% +$77.9K 0.28% 50
2022
Q2
$201K Buy
1,870
+75
+4% +$8.25K 0.31% 45
2022
Q1
$200K Buy
+1,795
New +$186K 0.16% 82

Other funds holding DUK

Prostatis Group's DUK Position: Q1 2026 in Review

Prostatis Group increased its Duke Energy (DUK) stake by 4% in Q1 2026, buying an estimated $14.4K and bringing the position to 2,993 shares worth $392K. The position accounts for 0.1% of the portfolio, ranked #115.

Prostatis Group first reported a position in DUK in Q1 2022 and has held it in 17 quarters since. The position peaked at $406K in Q1 2025. 2,467 funds tracked by Wall St. Rank hold DUK as of Q1 2026.

  • Prostatis Group held 2,993 shares of Duke Energy worth $392K as of Q1 2026.
  • Prostatis Group bought 115 Duke Energy shares in Q1 2026, an estimated $14.4K.
  • Duke Energy made up 0.1% of Prostatis Group's portfolio in Q1 2026, its #115 holding.
  • Prostatis Group first reported a position in Duke Energy in Q1 2022 and has held it in 17 quarters since.
  • Prostatis Group's Duke Energy position peaked at $406K in Q1 2025.
  • 2,467 funds tracked by Wall St. Rank held Duke Energy as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.